medigraphic.com
Colegio de Medicina Interna de México.

2018, Number 3

<< Back Next >>

Med Int Mex 2018; 34 (3)

Cerebral venous sinus thrombosis during puerperium

Cruz-Hernández V, León-Tapia S, López-Gómez P, Cruz-Acevedo DA, Arango-Díaz Á

Language: Spanish
References: 24
Page: 388-393
PDF size: 357.06 Kb.


ABSTRACT

Background: Cerebral venous sinus thrombosis is a cerebrovascular disorder characterized by partial or complete blockage of one or more venous sinuses or cerebral veins.
Material and Method: A retrospective, observational and descriptive study was done in which records of obstetric patients admitted to the Internal Medicine service of Hospital Dr. Aurelio Valdivieso, Oaxaca, Mexico, were reviewed in a period of five years (2009-2014), who had a clinical and radiological diagnosis of cerebral venous sinus thrombosis.
Results: Six patients were found, with an average age of 23 years with the diagnosis of cerebral venous sinus thrombosis, six were enrolled in the postpartum period. Occasional causes were: three primary antiphospholipid antibodies syndrome, one had protein C deficiency, one case was receiving oral hormonal and one case of idiopathic etiology. In relation to treatment, all received anticoagulation with good response.
Conclusion: Cerebral venous sinus thrombosis presented in our midst at least once a year, the most common cause is autoimmune antiphospholipid antibodies syndrome/ cerebral venous sinus thrombosis type.


REFERENCES

  1. Ribes MF. Des recherches faites sur la phlébite. Revue Médicale Française et Etrangère et Journal de Clinique de l’Hôtel-Dieu et de la Charité de Paris 1825;3:5-41.

  2. Abercrombie J. Pathological and practical researches on the diseases of the brain and spinal cord. 1828.

  3. Kalbag R, Woolf A. Cerebral venous thrombosis. London: Oxford University Press; 1967.

  4. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagar-Rementeria F. SCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-670.

  5. Hameed B, Syed NA. Prognostic indicators in cerebral venous sinus thrombosis. J Pak Med Assoc 2006;56:551-554.

  6. Chater Cure G, García N, Peña G, Jiménez E. Hemorragia subaracnoidea: presentación inusual de una trombosis de senos venosos. Rev Chil Neurocirug 2008;30:68-72.

  7. Amaya-González P, Ramírez SF, Hernán-Rodríguez J. Trombosis venosa cerebral, descripción clínica de una serie de casos en adultos de Bogotá-Colombia. Acta Neurol Colomb 2012;28:2.

  8. Sidhom Y, Mansour M, Messelmani M, Derbali H, Fekih- Mrissa N, Zaouali J, Mrissa R. Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort. J Stroke Cerebrovasc Dis 2014 Jul;23(6):1291-5.

  9. Narayan D, Kaul S, Ravishankar K, Suryaprabha T, Bandaru VC, Mridula KR, Jabeen SA, Alladi S, Meena AK, Borgohain R. Risk factors, clinical profile, and longterm outcome of 428 patients of cerebral sinus venous thrombosis: insights from Nizam’s Institute Venous Stroke Registry, Hyderabad (India). Neurol India 2012 Mar-Apr;60(2):154-9.

  10. Wilson WA, Gharavi AE, Koike T, Lockshin MD. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.

  11. Miyakis S, Lockshin MD, Atsumi T, Branch DW, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.

  12. Devreese KM. Antiphospholipid antibody testing and standardization. Int J Lab Hematol 2014;36:352-363.

  13. Coriu L, Ungureanu R, Talmaci R, Uscatescu V, et al. Hereditary thrombophilia and thrombotic events in pregnancy: single-center experience. J Med Life 2014 Oct-Dec;7(4):567-71.

  14. Kruthika-Vinod TP, Nagaraja D, Christopher R. Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis. J Clin Neurosci 2012 Jan;19(1):190-1.

  15. Yadav DD, De T, Nagaraja D, Christopher R. Protein Z G79A polymorphism and puerperal cerebral venous thrombosis. Clin Appl Thromb Hemost 2014 Jun 6.

  16. Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev 2015 Aug 27;8.

  17. Amoozegar F, Ronksley PE, Sauve R, Menon BK. Hormonal contraceptives and cerebral venous thrombosis risk: A systematic review and meta-analysis. Front Neurol 2015;6:7.

  18. Coutinho JM, Zuurbier SM, Gaartman AE, Dikstaal AA, Stam J, Middeldorp S, Cannegieter SC. Association between anemia and cerebral venous thrombosis: case-control study. Stroke 2015 Aug 13.

  19. Thammishetti V, Dharanipragada S, Basu D, Ananthakrishnan R, Surendiran D. A prospective study of the clinical profile, outcome and evaluation of d-dimer in cerebral venous thrombosis. J Clin Diagn Res 2016 Jun;10(6).

  20. Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 2014 Apr 3;370(14):1307-15.

  21. Bushnell C, Saposnik G. Evaluation and management of cerebral venous thrombosis. Cerebrovasc Dis 2014 Apr;20:335-51.

  22. The EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010;363:2499-2510.

  23. Skeik N, Rumery KK, Rodriguez GT. The new era of anticoagulation. Ann Vasc Surg 2014;28(2): 503-14.

  24. Guang-Jun Xu, Tuan-Zhi Chen, Gui-Sheng Jiang, Lu-Su Yao, Mei-Jia Zhu. Local thrombolytic therapy in severe cerebral venous sinus thrombosis during puerperium. Int J Clin Exp Med 2015;8(2):2621-2627.




2020     |     www.medigraphic.com